Trial · NCT07458880
Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control
NCT07458880, Not applicable, Recruiting, The University of Hong Kong
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control. Trials, record NCT07458880. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07458880
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control
- NCT number
- NCT07458880
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 140 participants, estimated
- Lead sponsor
- The University of Hong Kong
- Conditions
- Intracerebral Hemorrhage
- Interventions
- Exforge HCT® or Three Individual drug amlodipine + valsartan + hydrochlorothiazide
- First posted
- 2026-03-09
- Last updated
- 2026-03-09
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Hypertension Control | 1 month | Controlled hypertension (office SBP \<130 mmHg) 1 month after ICH |
| Secondary | Hypertension Control Rate | 3, 6 and 12 months after ICH | Controlled hypertension rate at 3, 6 and 12 months after ICH |
| Secondary | Blood Pressure changes post ICH | At admission time, 1 and 3 months after ICH | Change of BP from admission to one and three months |
| Secondary | Ambulatory Blood Pressure | At one and three months after ICH | 24-hour ambulatory BP at one and three months after ICH |
| Secondary | Drug Safety | 1 year | Drug safety by types, frequency and severity of adverse events (AEs) |
| Secondary | Drug tolerability | 1 year | Drug tolerability by the rate of treatment withdrawal due to AEs |
| Secondary | Treatment Satisfaction | At 3 and 12 months after ICH | 1. Adherence to Refills and Medications Scale (ARMS-12) at 3 and 12 months 2. Patient satisfaction survey with the Treatment Satisfaction Questionnaire for Medication (TSQM) at 3 and 12 months |
| Secondary | Cerebral and Cardiovascular Recurrence | 1 year | Recurrent ICH, stroke, cardiovascular events at 12 months |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07458880
GET https://conductscience.org/api/trials/v1/NCT07458880/registered